Realize the Potential of Genomic Data in Drug Development

Ovation offers a consented biobank of ~1.6 million samples that can be sequenced to generate genomic data across more than 60 pre-defined disease cohorts

Consented samples (Sample types include FFPE tissue, nasopharyngeal swabs, preserved saliva, whole blood, total nucleic, and more)

Unique patients

Pre-defined disease cohorts

Samples are sequenced to deliver:

  • Whole genome sequencing data (30X depth)
  • Whole exome sequencing data
  • RNA sequencing data
  • And more

Cohorts are curated through linkage to phenotypic data using common tokens.

Phenotypic and clinical data including treatment exposure, comorbidities, lab values, and disease severity metrics from top claims, EHR, and lab real-world data sources is linked to omics data from Ovation’s database.

Learn more about how your organization can use Ovation’s omics data to accelerate R&D

For an expert consultation on how we can work together,
complete this form and we’ll be in touch soon.

Explore more about
Ovation’s Data Products


Resources_Datavant Webinar

Linking Genomic and Phenotypic Data to Understand the Patient Journey

Data in Action

Picture of the Crohn's & Colitis Congress academic poster on black background

Ovation’s Poster from the 2024 Crohn’s & Colitis Congress

Thought Leadership


Ovation Presents at the 2023 AWS Life Sciences Executive Symposium

Linking Genomic and Phenotypic Data to Better Understand the Patient Journey

In partnership with Datavant, we explore how researchers can overcome the challenges posed by..

Case Study: Realizing the value of biospecimens for life sciences research in IBD


We looking forward to speaking with you!